Xspray Pharma AB (publ) (STO:XSPRAY)
Sweden
· Delayed Price · Currency is SEK 26.95
+0.05 (0.19%)
Apr 28, 2026, 5:29 PM CET
Xspray Pharma AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Other Revenue | 2.47 | - | - | - | - | Upgrade
|
| Revenue | 2.47 | - | - | - | - | Upgrade
|
| Gross Profit | 2.47 | - | - | - | - | Upgrade
|
| Selling, General & Admin | 151.1 | 203.88 | 169.57 | 109.6 | 58.38 | Upgrade
|
| Research & Development | 10.75 | 79.36 | 40.26 | 22.22 | 38.57 | Upgrade
|
| Other Operating Expenses | -0.25 | - | -29.06 | -0.44 | - | Upgrade
|
| Operating Expenses | 161.6 | 283.24 | 180.77 | 131.38 | 96.95 | Upgrade
|
| Operating Income | -159.13 | -283.24 | -180.77 | -131.38 | -96.95 | Upgrade
|
| Interest Expense | -16.85 | -1.93 | -0.68 | -0.01 | -0 | Upgrade
|
| Interest & Investment Income | 2.22 | 3.3 | 2.73 | 1.42 | 1.26 | Upgrade
|
| Currency Exchange Gain (Loss) | 2.22 | -3.79 | -0.96 | -1.69 | -1 | Upgrade
|
| Other Non Operating Income (Expenses) | -0 | -0 | - | - | -0 | Upgrade
|
| EBT Excluding Unusual Items | -171.55 | -285.66 | -179.68 | -131.67 | -96.7 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | -0.02 | -0.01 | - | - | Upgrade
|
| Pretax Income | -171.55 | -285.67 | -179.68 | -131.67 | -96.7 | Upgrade
|
| Income Tax Expense | -0.1 | -0.15 | -0.02 | - | - | Upgrade
|
| Net Income | -171.44 | -285.52 | -179.67 | -131.67 | -96.7 | Upgrade
|
| Net Income to Common | -171.44 | -285.52 | -179.67 | -131.67 | -96.7 | Upgrade
|
| Shares Outstanding (Basic) | 38 | 33 | 27 | 21 | 19 | Upgrade
|
| Shares Outstanding (Diluted) | 38 | 33 | 27 | 21 | 19 | Upgrade
|
| Shares Change (YoY) | 16.04% | 24.61% | 26.21% | 9.53% | 11.77% | Upgrade
|
| EPS (Basic) | -4.46 | -8.62 | -6.76 | -6.25 | -5.03 | Upgrade
|
| EPS (Diluted) | -4.46 | -8.62 | -6.76 | -6.25 | -5.03 | Upgrade
|
| Free Cash Flow | -193.16 | -226.75 | -205.97 | -134.65 | -52.92 | Upgrade
|
| Free Cash Flow Per Share | -5.02 | -6.84 | -7.75 | -6.39 | -2.75 | Upgrade
|
| Gross Margin | 100.00% | - | - | - | - | Upgrade
|
| Operating Margin | -6453.12% | - | - | - | - | Upgrade
|
| Profit Margin | -6952.27% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | -7833.05% | - | - | - | - | Upgrade
|
| EBITDA | -156.54 | -277.76 | -174.27 | -123.04 | -89.07 | Upgrade
|
| D&A For EBITDA | 2.59 | 5.48 | 6.49 | 8.34 | 7.89 | Upgrade
|
| EBIT | -159.13 | -283.24 | -180.77 | -131.38 | -96.95 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.